BSE filing, BSE: 544353. Summary written from the filing by ALFA Finder's alert engine.
Amwill Health Care Ltd: key numbers
- Share price
- ₹43.00
- Market cap
- ₹86.02 Cr
- Revenue (annual)
- ₹45.49 Cr
- Net profit (annual)
- ₹11.42 Cr
- P/E (TTM)
- 7.5×Sector 46.1×
- Promoter holding
- 70.65%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amwill Health Care Ltd
All →Amwill Health Care Dividend
Amwill Health Care's board declared an interim dividend of Rs.0.05 per equity share for FY 2026-27 on 23 October 2026. The record date is 30 October 2026 and payment is proposed by 22 November 2026.
Amwill Health Care H1 FY27 Results: Net Profit ₹3.7 Cr, Down 50.7% YoY
Amwill Health Care Ltd reported revenue from operations of ₹22.6 Cr (-7.0% YoY) and net profit of ₹3.7 Cr (-50.7% YoY) for H1 FY27.
- Key figure
- Net profit ₹3.7 Cr · -50.7% YoY
Amwill Health Care Board Meeting Date
Amwill Health Care has scheduled a board meeting for October 23, 2026, to review H1 financial results and consider declaring an interim dividend.
Amwill Health Care Other Announcement
This filing is a standard quarterly Shareholding Pattern submission in accordance with SEBI Regulation 31(1)(b) for Amwill Health Care Ltd as of September 30, 2026.
Amwill Health Care Regulatory Approval
Amwill Health Care received an import license from CDSCO for FoliColor hair products, enabling the company to commence commercial sale and import into India.
Amwill Health Care Acquisition Worth ₹3 Cr
Amwill Health Care Limited approved investments of ₹3 Crore into two Alternative Investment Funds. The company will invest ₹1.50 Crore each in Vivriti Vihaan Trust and Neo Income Plus Fund III.
- Value
- ₹3.00 Cr
- Execution
- Ensuing month(s)
Other board meeting date announcements
All →RateGain Travel Technologies Board Meeting Date
RateGain Travel Technologies will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window closes from 1 October 2026 until 48 hours after results.
Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.
Parag Milk Foods Board Meeting Date
Parag Milk Foods has notified BSE of a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window closure runs from 1 October to 5 November 2026.
Vedant Fashions Board Meeting Date
Vedant Fashions will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half-year ended September 2026. The meeting is a prior intimation, so no results are approved yet.
Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.